Showing results (921-930 of 3,769) with videos related to
Sort By:
Pageof 377
Radiation Oncology (London, England)|December 30, 2022
A review of radiomics and genomics applications in cancers: the way towards precision medicineSimin Li, Baosen ZhouRadiation Oncology (London, England)|December 30, 2022
Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective studyLi Jiang, Jie Zhu, Xue Chen, et al.Radiation Oncology (London, England)|December 27, 2022
Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signaturesYongbin Cui, Zhengjiang Li, Mingyue Xiang, et al.Radiation Oncology (London, England)|December 28, 2022
Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastasesMasanori Hirata, Kazuaki Yasui, Naofumi Oota, et al.Radiation Oncology (London, England)|December 20, 2022
Ultra-low-dose radiotherapy in the treatment of ocular adnexal lymphoma: a prospective studyXiaolu Yang, Ruonan Wang, Xiaochun Yuan, et al.Radiation Oncology (London, England)|June 6, 2022
Initial clinical experience of surface guided stereotactic radiation therapy with open-face mask immobilization for improving setup accuracy: a retrospective studyShun Zhou, Junyu Li, Xianggao Zhu, et al.Radiation Oncology (London, England)|December 5, 2022
Intensity modulated proton therapy for early-stage glottic cancer: high-precision approach to laryngeal function preservation with exceptional treatment tolerabilityThomas Held, Henrik Franke, Kristin Lang, et al.Radiation Oncology (London, England)|June 10, 2022
Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trialHui Li, Ying Fang, Dayong Gu, et al.Radiation Oncology (London, England)|June 11, 2022
Efficacy and safety of radiotherapy plus anti-PD1 versus transcatheter arterial chemoembolization plus sorafenib for advanced hepatocellular carcinoma: a real-world studyJian-Xu Li, Wen-Xiang Deng, Shi-Ting Huang, et al.Radiation Oncology (London, England)|May 24, 2019
Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trialFlorence Legouté, René-Jean Bensadoun, Valérie Seegers, et al.Pageof 377